Preclinical Assessment of Phage Therapy for Pathogen Decolonization
$375,000Y01FY2022AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
To develop animal models for studying the use of bacteriophage therapy to decolonize or treat MRSA and VRE, antibacterial resistant infections.
View original record on NIH RePORTER →